Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Mystery solved of source of anti-cancer effects in pregnancy hormone

24.06.2014

University of Montreal scientists have identified a small molecule found in pregnant women’s urine that apparently blocks the growth of several types of cancers, including AIDS-related Kaposi’s sarcoma, which currently has no cure. Their study results will be presented Monday at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.

These findings resurrect a nearly 20-year controversy over whether human chorionic gonadotropin (hCG), a hormone produced in high amounts during pregnancy, or its core fragments, or something else yields anti HIV and cancer-fighting activity against Kaposi’s sarcoma tumors.

Some researchers in the mid-1990s reported that “clinical-grade” hCG—crude or partially purified preparations of hCG extracted from pregnant women’s urine—shrunk these AIDS tumors, but they later retracted their original claim that hCG itself was the active component responsible for activity against Kaposi’s sarcoma.

“The real compound has been elusive,” said principal investigator Tony Antakly, PhD, a biochemist at the University of Montreal, who said it has taken his small group of researchers more than 12 years to find the answer.

Early on, and shortly before this retraction, Antakly’s group tested highly purified or recombinant hCG in Kaposi’s sarcoma cells and found no anti-cancer effects. They concluded that the cancer-fighting compound, closely associated with the pregnancy hormone, must be removed when hCG is purified.

Both clinical-grade and recombinant hCG are approved by the U.S. Food and Drug Administration as prescription medications for the treatment of select cases of female infertility and as hormone treatment for men.

The researchers narrowed their search to small molecular weight factors present in clinical-grade hCG that they called hCG-like inhibitory products, or HIP. To find the active molecule or part of a molecule, they used a biochemical approach involving systematically splitting the molecule (fractionation), repeatedly performing biological assays and chemical characterization.

Their results indicate that a small metabolite—the product of transformation of a larger molecule carried throughout blood and urine—into a potent bioactive metabolite that affects living tissue.

“We don’t know if it changes only when needed,” Antakly said. “Perhaps in cancer, it changes to fight the disease.”

This HIP metabolite, they discovered, rides “piggyback” on the larger hCG molecule, which chaperones it to target cells. When hCG is extensively purified, the metabolite loses its ride and disappears, Antakly stated.

However, when he and his colleagues exposed human Kaposi’s sarcoma cells in tissue cultures to hCG after purification from pregnant women’s urine, he said the active HIP metabolite “wiped out the cancer cells completely.”

Antakly said they do not yet know whether a synthetic replica of the HIP metabolite, which they are developing, is safe and effective to use at high doses in patients with cancer. However, in preliminary tests in cancer patients, they have shown that the “natural” HIP (purified from clinical-grade hCG) is safe and has anti-cancer activity.

William Raillant-Clark | AlphaGalileo
Further information:
http://www.umontreal.ca

Further reports about: Mystery anti-cancer cancer-fighting hormone metabolite pregnancy sarcoma synthetic tumors urine

More articles from Health and Medicine:

nachricht Cystic fibrosis alters the structure of mucus in airways
28.06.2017 | University of Iowa Health Care

nachricht Mice provide insight into genetics of autism spectrum disorders
28.06.2017 | University of California - Davis

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Supersensitive through quantum entanglement

28.06.2017 | Physics and Astronomy

X-ray photoelectron spectroscopy under real ambient pressure conditions

28.06.2017 | Physics and Astronomy

Mice provide insight into genetics of autism spectrum disorders

28.06.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>